Australia markets open in 7 hours 50 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.62-1.47 (-7.70%)
At close: 04:00PM EST
17.62 0.00 (0.00%)
After hours: 07:58PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts18121818
Avg. Estimate-0.59-0.62-1.96-2.59
Low estimate-0.7-0.69-2.16-3.06
High estimate-0.53-0.54-1.88-2.22
Year ago EPS-0.53-0.25-2.08-1.96
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts16111718
Avg. EstimateN/AN/A38.37M2.19M
Low estimateN/AN/A38MN/A
High estimateN/AN/A38.5M39.4M
Year ago salesN/A38.34MN/A38.37M
Sales growth (year/est)N/AN/AN/A-94.30%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.56-0.46-0.55-0.56
Actual EPS-0.53-0.25-0.53-0.57
Difference0.030.210.02-0.01
Surprise %5.40%45.70%3.60%-1.80%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.59-0.62-1.96-2.59
7 days ago-0.59-0.62-1.96-2.59
30 days ago-0.6-0.6-1.93-2.54
60 days ago-0.59-0.59-1.92-2.57
90 days ago-0.59-0.59-1.92-2.55
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days7368
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesALLOIndustrySector(s)S&P 500
Current qtr.-11.30%N/AN/AN/A
Next qtr.-148.00%N/AN/AN/A
Current year5.80%N/AN/AN/A
Next year-32.10%N/AN/AN/A
Next 5 years (per annum)1.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A